| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |